The Gross Margin of Emmaus Life Sciences Inc (EMMA) is 95.47%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 95.47% |
| 2022-12-31 | 85.92% |
| 2021-12-31 | 83.94% |
| 2020-12-31 | 90.29% |
| 2019-12-31 | 95.21% |
| 2018-09-30 | 37.12% |
| 2017-09-30 | 61.54% |
| 2016-09-30 | 88.89% |
| 2015-09-30 | 100.00% |
| 2014-09-30 | 50.00% |